ATIM-26. IMMUNOLOGIC TRENDS ASSOCIATED WITH PATIENT OUTCOMES IN A PHASE 1 CLINICAL TRIAL OF TOCA 511 AND TOCA FC IN RECURRENT HIGH GRADE GLIOMA

Toca 511 (vocimagene amiretrorepvec) is a cancer selective, retroviral replicating vector encoding a codon optimized, heat stabilized cytosine deaminase that converts Toca FC (extended-release 5- fluorocytosine, 5-FC) into the anticancer agent 5-fluorouracil. Preclinical evidence demonstrates that t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Accomando, William, Cloughesy, Timothy, Kalkanis, Steven, Mikkelsen, Tom, Landolfi, Joseph, Carter, Bob, Chen, Clark, Vogelbaum, Michael, Elder, James, Piccioni, David, Walbert, Tobias, Hogan, Daniel, Diago, Oscar, Gammon, Dawn, Haghighi, Ali, Kheoh, Thian, Gruber, Harry, Jolly, Douglas, Ostertag, Derek
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2018
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216133/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.021
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki